<DOC>
	<DOCNO>NCT00762268</DOCNO>
	<brief_summary>S-adenosyl-L-methionine ( SAMe ) dietary supplement antidepressant property . SAMe 's mechanism action remain unclear , appear distinct conventional antidepressant . The purpose study examine effect property mood bipolar subject persistent major depression unresponsive standard pharmacotherapy .</brief_summary>
	<brief_title>A Trial SAMe Treatment-Resistant Bipolar Depression</brief_title>
	<detailed_description>Depression bipolar disorder significant source disease-related debility ; bipolar individual typically spend three fold much time depress manic hypomanic . Clinicians treat bipolar disorder often struggle provide relief depressive symptom often treatment resistant unipolar depression . To complicate matter , risk/benefit ratio currently available antidepressant source debate within field psychiatry . S-adenosyl-L-methionine ( SAMe ) dietary supplement well-established antidepressant property . SAMe 's mechanism action remain unclear , appear distinct conventional antidepressant . The purpose study examine effect property mood bipolar subject persistent major depression unresponsive standard pharmacotherapy . An unusual aspect current study design schedule SAMe dosing . SAMe tablets administer intermittently steadily increase dosage . The purpose gradual intermittent dosage titration lessen risk antidepressant-induced mania seek minimum effective oral dose SAMe .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>bipolar disorder depress 312 month mood unresponsive least 2 treatment currently mood stabilizer therapeutic dos history mania adequate mood stabilizer rapid cycling bipolar disorder previous use SAMe current episode unstable medical illness include parkinson 's disease methotrexate use pregnancy substance abuse/dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>SAMe</keyword>
	<keyword>alternative treatment</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>depression</keyword>
	<keyword>bipolar depression</keyword>
	<keyword>treatment-resistant depression</keyword>
</DOC>